In the latest session, Kezar Life Sciences Inc (NASDAQ: KZR) closed at $0.87 down -1.10% from its previous closing price of $0.88. In other words, the price has decreased by -$0.0097 from its previous closing price. On the day, 494765 shares were traded. KZR stock price reached its highest trading level at $0.8980 during the session, while it also had its lowest trading level at $0.8400.
Ratios:
For a deeper understanding of Kezar Life Sciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.66 and its Current Ratio is at 11.66. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.08.
On December 08, 2021, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $19.Wells Fargo initiated its Overweight rating on December 08, 2021, with a $19 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KZR now has a Market Capitalization of 64.06M and an Enterprise Value of -118.38M. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.05 while its Price-to-Book (P/B) ratio in mrq is 0.34. Its current Enterprise Value per Revenue stands at -16.91 whereas that against EBITDA is 1.19.
Stock Price History:
Over the past 52 weeks, KZR has reached a high of $4.23, while it has fallen to a 52-week low of $0.67. The 50-Day Moving Average of the stock is 0.9106, while the 200-Day Moving Average is calculated to be 1.3459.
Shares Statistics:
For the past three months, KZR has traded an average of 633.80K shares per day and 588.62k over the past ten days. A total of 72.78M shares are outstanding, with a floating share count of 61.87M. Insiders hold about 15.01% of the company’s shares, while institutions hold 65.11% stake in the company. Shares short for KZR as of Feb 29, 2024 were 3.18M with a Short Ratio of 5.02, compared to 3.05M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.37% and a Short% of Float of 4.52%.
Earnings Estimates
There are 5 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.34 for the current quarter, with a high estimate of -$0.28 and a low estimate of -$0.41, while EPS last year was -$0.31. The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.24 and low estimates of -$0.45.
Analysts are recommending an EPS of between -$0.9 and -$1.83 for the fiscal current year, implying an average EPS of -$1.3. EPS for the following year is -$1.16, with 5 analysts recommending between -$0.85 and -$1.55.
